Study to investigate the effect of inhaled tiotropium bromide on neurokinin-A induced bronchoconstriction in patients with mild-to-moderate asthma

Trial Profile

Study to investigate the effect of inhaled tiotropium bromide on neurokinin-A induced bronchoconstriction in patients with mild-to-moderate asthma

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2014

At a glance

  • Drugs Tiotropium bromide (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2011 Results presented at the 107th International Conference of the American Thoracic Society.
    • 15 Jun 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 15 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top